Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSRX Industries is a U.S. public holding company historically focused on the acquisition, development, and operation of medical cannabis dispensaries and related cannabinoid product businesses. The company previously operated medicinal cannabis dispensaries in Puerto Rico and California and described expansion plans into distribution, extraction, light manufacturing, delivery, and CBD retail. In November 2020, GSRX announced the sale of its Puerto Rico cannabis operations and assets, indicating a significant contraction of its operating footprint. As of recent OTC market data, the company remains quoted under the symbol GSRX but trades on the Expert Market/unsolicited quote basis, suggesting limited public disclosure and a distressed or minimally active status. It is not a traditional biotech or pharmaceutical drug developer and no conventional drug pipeline has been identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GSRX Industries.